Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules

被引:10
作者
Beisa, Augustas [1 ,2 ]
Kvietkauskas, Mindaugas [1 ,2 ]
Beisa, Virgilijus [1 ,2 ]
Stoskus, Mindaugas [1 ,2 ]
Ostaneviciute, Elvyra [1 ,2 ]
Jasiunas, Eugenijus [3 ]
Griskevicius, Laimonas [1 ,2 ]
Seinin, Dmitrij [4 ]
Sileikyte, Aukse [1 ]
Strupas, Kestutis [1 ,2 ]
机构
[1] Vilnius Univ, Fac Med, MK Ciurlionio Str 21, LT-03101 Vilnius, Lithuania
[2] Vilnius Univ Hosp Santaros Klin, Vilnius, Lithuania
[3] Mykolas Romeris Univ, Vilnius, Lithuania
[4] Vilnius Univ Hosp Santaros Klin, Natl Ctr Pathol, Vilnius, Lithuania
关键词
Bethesda system; BRAF mutation; fine-needle aspiration; papillary thyroid cancer; thyroid; RISK STRATIFICATION; ASPIRATION; CARCINOMA; MALIGNANCY; MANAGEMENT;
D O I
10.1055/a-0588-4885
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Ultrasound guided fine needle aspiration biopsy with cytologic analysis is an initial step in diagnostic of thyroid nodules. Unfortunately, up to 30% of biopsies are indeterminate and diagnostic surgery is required. The aim of this study was to estimate the diagnostic value of BRAF V600E mutation status combined with cytomorphological features for diagnosis of papillary thyroid cancer (PTC) in cytologically indeterminate thyroid nodules. Methods A prospective study analyzed patients who had ultrasound suspicious thyroid nodules, underwent fine needle aspiration and cytological examination, and were classified according to the Bethesda system. Patients from indeterminate diagnostic categories were examined for BRAF V600E mutation and 22 cytomorphological features, and underwent thyroid surgery. A binary logistic regression model was used to evaluate the diagnostic utility. Results A total of 219 patients met study criteria. After histological examination, 77 (35.2 %) patients were diagnosed with PTC and 142 (64.8 %) with benign nodular thyroid disease. According to logistic regression model, significant features for PTC diagnosis were: liquid colloid consistency, papillary structures, eosinophilic colloid bodies, and BRAF V600E mutation. Risk groups classified by this model have sensitivity of 80.5% (95% CI: 69.9 to 88.7), specificity of 99.3 % (95 % CI: 96.1 to 100), positive predictive value of 98.4 % (95 % CI: 89.8 to 99.8), negative predictive value of 90.4% (95% CI: 85.7 to 93.7), and accuracy of 92.7% (95% CI: 88.4 to 95.8) for PTC diagnosis. Conclusions Evaluation of BRAF V600E mutation status combined with cytomorphological features for diagnosis of PTC in cytologically indeterminate thyroid nodules can significantly improve diagnostic accuracy and reduce the number of diagnostic operations (calculator available at www.ptc-calc.we2host.lt).
引用
收藏
页码:247 / 254
页数:8
相关论文
共 26 条
[1]   The utility of the Bethesda category and its association with BRAF mutation in the prediction of papillary thyroid cancer stage [J].
Beisa, Augustas ;
Kvietkauskas, Mindaugas ;
Beisa, Virgilijus ;
Stoskus, Mindaugas ;
Ostaneviciute, Elvyra ;
Jasiunas, Eugenijus ;
Griskevicius, Laimonas ;
Strupas, Kestutis .
LANGENBECKS ARCHIVES OF SURGERY, 2017, 402 (02) :227-234
[2]   Differential expression of transforming growth factor-beta in benign vs. papillary thyroid cancer nodules; a potential diagnostic tool? [J].
Brace, Matthew D. ;
Wang, Jun ;
Petten, Mark ;
Bullock, Martin J. ;
Makki, Fawaz ;
Trites, Jonathan ;
Taylor, S. Mark ;
Hart, Robert D. .
JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2014, 43
[3]   The Bethesda System for Reporting Thyroid Cytopathology [J].
Cibas, Edmund S. ;
Ali, Syed Z. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (05) :658-665
[4]  
Rodrigues HGC, 2012, ENDOCR J, V59, P417
[5]   Investigation of BRAF V600E Mutation in Papillary Thyroid Carcinoma and Tumor-Surrounding Nontumoral Tissues [J].
Daglar-Aday, Aynur ;
Toptas, Bahar ;
Ozturk, Tulin ;
Seyhan, Fatih ;
Saygili, Neslihan ;
Eronat, Allison Pinar ;
Akadam-Teker, Basak ;
Yilmaz-Aydogan, Hulya ;
Aksoy, Figen ;
Ozturk, Oguz .
DNA AND CELL BIOLOGY, 2013, 32 (01) :13-18
[6]   Evidence-Based Evaluation of the Thyroid Nodule [J].
Davies, Louise ;
Randolph, Gregory .
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2014, 47 (04) :461-+
[7]   Examining the Bethesda criteria risk stratification of thyroid nodules [J].
Deniwar, Ahmed ;
Hambleton, Catherine ;
Thethi, Tina ;
Moroz, Krzysztof ;
Kandil, Emad .
PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (05) :345-348
[8]   Diagnostic value of fine needle aspiration BRAFV600E mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis [J].
Fnais, Naif ;
Soobiah, Charlene ;
AL-Qahtani, Khalid ;
Hamid, Jemila ;
Perrier, Laure ;
Straus, Sharon E. ;
Tricco, Andrea C. .
HUMAN PATHOLOGY, 2015, 46 (10) :1443-1454
[9]   The utility of thyroid ultrasonography in the management of thyroid nodules [J].
Gamme, Gary ;
Parrington, Tyler ;
Wiebe, Edward ;
Ghosh, Sunita ;
Litt, Brendan ;
Williams, David C. ;
McMullen, Todd P. W. .
CANADIAN JOURNAL OF SURGERY, 2017, 60 (02) :134-139
[10]   2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J].
Haugen, Bryan R. ;
Alexander, Erik K. ;
Bible, Keith C. ;
Doherty, Gerard M. ;
Mandel, Susan J. ;
Nikiforov, Yuri E. ;
Pacini, Furio ;
Randolph, Gregory W. ;
Sawka, Anna M. ;
Schlumberger, Martin ;
Schuff, Kathryn G. ;
Sherman, Steven I. ;
Sosa, Julie Ann ;
Steward, David L. ;
Tuttle, R. Michael ;
Wartofsky, Leonard .
THYROID, 2016, 26 (01) :1-133